IPO-话题@MedSci

#IPO#

54篇内容 | 1948人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1510839, encodeId=6d9915108395d, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=迎来IPO热，慢病管理数字医疗模式在美国跑通了吗？, objectType=article, longId=175330, objectId=e77b1e53306c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e77b1e53306c, replyNumber=0, likeNumber=61, createdTime=2019-07-14, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e77b1e53306c, moduleTitle=迎来IPO热，慢病管理数字医疗模式在美国跑通了吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e77b1e53306c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510838, encodeId=0dea1510838ab, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=微医在银川启动健康医疗大数据战略合作，透露赴港IPO计划不变, objectType=article, longId=168980, objectId=2356168980c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2356168980c4, replyNumber=0, likeNumber=64, createdTime=2019-06-24, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2356168980c4, moduleTitle=微医在银川启动健康医疗大数据战略合作，透露赴港IPO计划不变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2356168980c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510837, encodeId=135f151083ec5, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=2019 IPOG共识建议：儿童后鼻孔闭锁的诊断以及术前、术中和术后护理, objectType=article, longId=166737, objectId=e932166e37fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e932166e37fc, replyNumber=0, likeNumber=63, createdTime=2019-05-25, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e932166e37fc, moduleTitle=2019 IPOG共识建议：儿童后鼻孔闭锁的诊断以及术前、术中和术后护理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e932166e37fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510836, encodeId=0177151083673, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=施一公教授领衔的诺诚健华估值约8.6亿美元，拟港股IPO, objectType=article, longId=165894, objectId=5c0416589440, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c0416589440, replyNumber=0, likeNumber=0, createdTime=2019-05-13, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c0416589440, moduleTitle=施一公教授领衔的诺诚健华估值约8.6亿美元，拟港股IPO, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c0416589440)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510835, encodeId=11841510835d0, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=Neurochem Res：AdipoRon通过减轻线粒体功能障碍保护脑出血后继发性脑损伤, objectType=article, longId=164825, objectId=0056164825d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0056164825d2, replyNumber=0, likeNumber=87, createdTime=2019-04-24, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0056164825d2, moduleTitle=Neurochem Res：AdipoRon通过减轻线粒体功能障碍保护脑出血后继发性脑损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0056164825d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510834, encodeId=99a01510834dc, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=信达生物获2018“亚太区年度IPO”暨年度“更佳香港股票发行奖”, objectType=article, longId=161350, objectId=2713161350cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2713161350cb, replyNumber=0, likeNumber=76, createdTime=2019-03-01, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2713161350cb, moduleTitle=信达生物获2018“亚太区年度IPO”暨年度“更佳香港股票发行奖”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2713161350cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510833, encodeId=10ba15108335b, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=药明康德拟在香港IPO筹集10.64亿美元，预计12月13日挂牌上市, objectType=article, longId=154757, objectId=0321154e5742, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0321154e5742, replyNumber=0, likeNumber=62, createdTime=2018-12-01, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0321154e5742, moduleTitle=药明康德拟在香港IPO筹集10.64亿美元，预计12月13日挂牌上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0321154e5742)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510832, encodeId=04111510832be, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=1药网赴美IPO，医药电商上市潮开启？, objectType=article, longId=147015, objectId=7cab14e0158d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cab14e0158d, replyNumber=0, likeNumber=63, createdTime=2018-08-21, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cab14e0158d, moduleTitle=1药网赴美IPO，医药电商上市潮开启？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cab14e0158d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510831, encodeId=1c401510831bc, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=路透社：两家大陆创新药企确认“弃美赴港” 或开启8亿美元IPO, objectType=article, longId=136923, objectId=5f78136923bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f78136923bc, replyNumber=0, likeNumber=48, createdTime=2018-05-02, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f78136923bc, moduleTitle=路透社：两家大陆创新药企确认“弃美赴港” 或开启8亿美元IPO, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f78136923bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510830, encodeId=5c89151083057, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=港交所IPO绿色通道开启！生物科技公司赴港上市潮来了？, objectType=article, longId=136889, objectId=7dcb13688983, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7dcb13688983, replyNumber=0, likeNumber=65, createdTime=2018-05-02, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7dcb13688983, moduleTitle=港交所IPO绿色通道开启！生物科技公司赴港上市潮来了？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7dcb13688983)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510829, encodeId=a28015108297b, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=为何医药制造行业IPO过会率如此低, objectType=article, longId=135948, objectId=305113594871, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=305113594871, replyNumber=0, likeNumber=32, createdTime=2018-04-21, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=305113594871, moduleTitle=为何医药制造行业IPO过会率如此低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=305113594871)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510828, encodeId=0d27151082863, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=Int Ophthalmol：视网膜中央静脉阻塞患者房水中lipocalin-2水平升高, objectType=article, longId=133575, objectId=815f1335e5b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=815f1335e5b9, replyNumber=0, likeNumber=67, createdTime=2018-03-28, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=815f1335e5b9, moduleTitle=Int Ophthalmol：视网膜中央静脉阻塞患者房水中lipocalin-2水平升高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=815f1335e5b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510827, encodeId=a71e151082e76, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=盘点中国医疗 “独角兽” 或驶入IPO快车道, objectType=article, longId=133537, objectId=875b13353e04, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=875b13353e04, replyNumber=0, likeNumber=53, createdTime=2018-03-28, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=875b13353e04, moduleTitle=盘点中国医疗 “独角兽” 或驶入IPO快车道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=875b13353e04)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510826, encodeId=9cde151082617, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=Adipocyte：研究揭示干细胞分化过程中miRNA表达发生改变的机制, objectType=article, longId=132683, objectId=81ad13268340, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81ad13268340, replyNumber=0, likeNumber=61, createdTime=2018-03-18, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81ad13268340, moduleTitle=Adipocyte：研究揭示干细胞分化过程中miRNA表达发生改变的机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81ad13268340)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510825, encodeId=611515108256c, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=医疗健康企业A股IPO 器械行业回报更优, objectType=article, longId=129506, objectId=e1ab1295068e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1ab1295068e, replyNumber=0, likeNumber=46, createdTime=2018-02-11, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1ab1295068e, moduleTitle=医疗健康企业A股IPO 器械行业回报更优, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1ab1295068e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510824, encodeId=de541510824cc, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=Bipolar disorders：长期使用锂，大脑发生了什么？, objectType=article, longId=118008, objectId=92c4118008ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92c4118008ba, replyNumber=0, likeNumber=74, createdTime=2017-10-30, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92c4118008ba, moduleTitle=Bipolar disorders：长期使用锂，大脑发生了什么？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=92c4118008ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510823, encodeId=10ae15108236f, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=2017 IPOG共识指南：Ⅰ型喉裂的诊断和管理, objectType=article, longId=113189, objectId=3850113189d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3850113189d6, replyNumber=0, likeNumber=52, createdTime=2017-09-20, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3850113189d6, moduleTitle=2017 IPOG共识指南：Ⅰ型喉裂的诊断和管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3850113189d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510822, encodeId=35371510822df, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=玻尿酸生产商IPO引热议：九州通入股, objectType=article, longId=105787, objectId=b7be105e87a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b7be105e87a0, replyNumber=0, likeNumber=55, createdTime=2017-07-19, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b7be105e87a0, moduleTitle=玻尿酸生产商IPO引热议：九州通入股, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b7be105e87a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510821, encodeId=20ae151082156, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=Inflamm bowel dis：乳酸乳球菌中先天性免疫蛋白Lipocalin-2的异位表达可以保护肠道, objectType=article, longId=102962, objectId=2242102962b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2242102962b0, replyNumber=0, likeNumber=54, createdTime=2017-06-24, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2242102962b0, moduleTitle=Inflamm bowel dis：乳酸乳球菌中先天性免疫蛋白Lipocalin-2的异位表达可以保护肠道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2242102962b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1510820, encodeId=c96515108203d, content=<a href='/topic/show?id=f98210002a8' target=_blank style='color:#2F92EE;'>#IPO#</a>, objectTitle=Nature: 抑制肥胖新靶点：骨分泌lipocalcin2蛋白通过黑皮质素（melanocortin）4受体抑制食欲, objectType=article, longId=91323, objectId=a3389132327, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3389132327, replyNumber=0, likeNumber=57, createdTime=2017-03-11, rootId=0, userName=dzx0922892, userId=0a1910256881, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3389132327, moduleTitle=Nature: 抑制肥胖新靶点：骨分泌lipocalcin2蛋白通过黑皮质素（melanocortin）4受体抑制食欲, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3389132327)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

IPO

2020-05-29

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

迎来IPO热，慢病管理数字医疗模式在美国跑通了吗？

2019-07-14

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

微医在银川启动健康医疗大数据战略合作，透露赴港IPO计划不变

2019-06-24

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

2019 IPOG共识建议：儿童后鼻孔闭锁的诊断以及术前、术中和术后护理

2019-05-25

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

施一公教授领衔的诺诚健华估值约8.6亿美元，拟港股IPO

2019-05-13

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

Neurochem Res：AdipoRon通过减轻线粒体功能障碍保护脑出血后继发性脑损伤

2019-04-24

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

信达生物获2018“亚太区年度IPO”暨年度“更佳香港股票发行奖”

2019-03-01

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

药明康德拟在香港IPO筹集10.64亿美元，预计12月13日挂牌上市

2018-12-01

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

1药网赴美IPO，医药电商上市潮开启？

2018-08-21

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

路透社：两家大陆创新药企确认“弃美赴港” 或开启8亿美元IPO

2018-05-02

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

港交所IPO绿色通道开启！生物科技公司赴港上市潮来了？

2018-05-02

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

为何医药制造行业IPO过会率如此低

2018-04-21

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

Int Ophthalmol：视网膜中央静脉阻塞患者房水中lipocalin-2水平升高

2018-03-28

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

盘点中国医疗 “独角兽” 或驶入IPO快车道

2018-03-28

一叶知秋 (审核中...)

前往app查看评论内容

#IPO#

Adipocyte：研究揭示干细胞分化过程中miRNA表达发生改变的机制

2018-03-18

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

医疗健康企业A股IPO 器械行业回报更优

2018-02-11

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

Bipolar disorders：长期使用锂，大脑发生了什么？

2017-10-30

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

2017 IPOG共识指南：Ⅰ型喉裂的诊断和管理

2017-09-20

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

玻尿酸生产商IPO引热议：九州通入股

2017-07-19

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

Inflamm bowel dis：乳酸乳球菌中先天性免疫蛋白Lipocalin-2的异位表达可以保护肠道

2017-06-24

dzx0922892 (审核中...)

前往app查看评论内容

#IPO#

Nature: 抑制肥胖新靶点：骨分泌lipocalcin2蛋白通过黑皮质素（melanocortin）4受体抑制食欲

2017-03-11

科室
- - 订阅+
  - 更多科室
工具
服务